Connect Biopharma

Apogee Therapeutics

This biotechnology company develops monoclonal antibody therapies for patients with inflammatory and immunological diseases, including atopic dermatitis, asthma and chronic obstructive pulmonary disease.

Aiolos Bio

This biopharmaceutical company develops monoclonal antibody therapies for patients suffering from respiratory and inflammatory conditions such as moderate-to-severe asthma.

Verona Pharma

This biopharmaceutical company develops and commercialises inhaled medicines to treat chronic respiratory diseases for adult patients with conditions such as chronic obstructive pulmonary disease.

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.

Belenos Biosciences

This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.

Windward Bio

The company develops long-acting monoclonal antibodies for patients with serious respiratory and dermatological diseases, including severe asthma, chronic obstructive pulmonary disease and atopic dermatitis.

Calluna Pharma

This clinical-stage company develops monoclonal antibodies to treat inflammatory and fibrotic diseases for patients with conditions like idiopathic pulmonary fibrosis and chronic kidney disease.

AirNexis

This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.